CD8A and melanoma: Building on the idea that allocating cholesterol towards cellular membranes in CD8+ T cells is beneficial for the anti-tumor response, researchers found that pharmacologic inhibition of ACAT1 in combination with anti-PD-1 treatment synergistically reduced the growth of mouse melanoma tumors[236].